May 2nd 2018
Following submission of the DTX Dossier to the Health & Safety Executive, Hydratech has received official HSE recognition and acceptance of our patented detoxification technology.
Specifically, the HSE has performed their own due diligence on the test-data provided and concur with our core statement of fact;
‘In accordance with Article 9 and Article 12 of Regulation (EC) No. 1272-2008 (CLP), CoolFlow DTX has been assessed as a mixture where adequate and reliable scientific information demonstrates the occurrence of synergistic and antagonistic effects, that renders the mixture non-toxic, as determined by an FDA certified laboratory’
HSE approval is in addition to and complementary with due diligence performed by; Toxicon, Inc., US Patent Office, Mediator A/S on behalf of the Danish Environment Agency, plus many engineering departments of customers now using Coolflow DTX, Thermox DTX etc.
As with all ‘revolutionary’ discoveries the subsequent implementation of DTX technology has taken several years to achieve. The advantage of which is; to provide all users and potential users the time needed to verify the credentials and performance of Coolflow DTX, Thermaflow DTX etc. However, the foresight and decisiveness shown by Arla Dairies – the first blue chip adopter of Coolflow DTX in 2010 - will always remain an important watershed.
The current list of those using DTX products is now extensive and contains many high-profile multinationals. For reasons of confidentiality (GDPR etc.) that list of end-users can be provided on a ‘case by case’ basis.
For further information on the DTX range or to obtain a copy of the DTX Dossier please call 01792 586800 or email to firstname.lastname@example.org.